| ²é¿´: 407 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[½»Á÷]
Çó·Òë³ÉÖÐÎÄ
|
|||
|
To date, different mutations have been reported that result in a complete deficiency, including: two deletions (295¨C298delTCAT and 1897delC), one splice-site mutation (IVS14+IG>A), four missense mutations (85T>C, 703C>T, 2657G>A, and 2983 G>T), a deletion of two nucleotides (1039¨C1040delTG), and the point mutations P86L, S201R, S492L, D949V and H978R [13]. The 85T>C mutation might be a common polymorphism, although functional analysis of a recombinantly expressed human protein carrying the 85T>C mutation showed no significant residual mutant enzyme activity [10,14]. An in-depth discussion of the clinical import of DPD can be found in a number of review articles, and two examples are provided in Refs. [37,38], which discuss the role of DPD in cancer therapy with 5FU |
» ²ÂÄãϲ»¶
ÊÕµ½¸´ÊÔµ÷¼Áµ«ÊÇÈ¥²»ÁË
ÒѾÓÐ7È˻ظ´
260Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¼±Ðèµ÷¼Á
ÒѾÓÐ10È˻ظ´
É격/¿¼²©
ÒѾÓÐ4È˻ظ´
»¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô
ÒѾÓÐ37È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ç󲩵¼£üÉúÎïÖÊ»ù¶à¿×̼/³¬¼¶µçÈÝ·½Ïò£¬ÒÑÓÐÏà¹Ø³É¹û£¬Ñ°ÄÜÔ´²ÄÁÏ/̼²ÄÁÏ·½ÏòÀÏʦ
ÒѾÓÐ3È˻ظ´
¶þ±½¼×ͪËáÀàÑÜÉúÎï
ÒѾÓÐ6È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¿ÆÑÐÐèÇó-Áò»¯Äøîܾ«¿óÑùÆ·
+1/399
ɽ¶«Õ÷Å®ÓÑ£¬×ø±ê¼ÃÄÏ
+1/172
Å·ÖÞ¡°CO2²¶¼¯Óë¼ÓÇâ´ß»¯×ª»¯¡±²©Ê¿ÕÐÆ¸£¨½Ý¿Ë-µÂ¹ú-˹ÂåÎÄÄáÑÇÈý¹úÏîÄ¿£©
+1/89
ÉϺ£½»Í¨´óѧÕÅÍò±óԺʿÍŶÓÕÐÆ¸¿ÆÑÐÖúÀíºÍ²©Ê¿ºòÑ¡ÈË
+1/87
¸´µ©´óѧ ¿ÎÌâ×é 2026Äê9ÔÂÅúÈëѧ-²©Ê¿ÕÐÆ¸
+1/85
🌈¶«Ý¸Àí¹¤-ÕÅÅÎÀÏʦ¿ÎÌâ×é ¡ª¡ª2026Äê˶ʿÑо¿ÉúÕÐ﹫¸æ
+1/84
½Î÷¿Æ¼¼Ê¦·¶´óѧ086ÉúÎïÓëÒ½Ò©
+1/40
ÕÐÊÕ08¿ªÍ·µÄѧ˶ר˶¾ù¿ÉÒÔ¼°0703£¬ÏßÉϸ´ÊÔ
+1/38
´ó¼ÒºÃ£¬Çë½Ì¸öÎÊÌ⣬Á¬Ðø¼·³ö½ºÆ¤£¬ÓÐûÓÐÔÚÏß½µµÍÆøÎ¶VOCµÄ·½Ê½¡£
+1/19
´óÁ¬º£Ñó´óѧ×ÊÔ´Óë»·¾³×¨Ë¶£¨0857£©½ÓÊÕµ÷¼ÁѧÉú
+1/14
Ï¡ÍÁ·¢¹â·ÖÎö£üºË¿Ç½á¹¹£üÊÙÃüÄâºÏ
+1/12
ºÓÄÏʡҽѧ¿ÆÑ§ÔºÍõÄþÀûԺʿ/ÃçÑåÑåÑо¿Ô±¿ÆÑÐÍŶӡ¢·üôË»ÛÑÛÔÆÆ½Ì¨ÍŶÓ2026Ä격ʿ¡¢Ë
+1/12
Ïã¸Û³ÇÊдóѧ»úеϵÕŃײ©Ê¿¿ÎÌâ×éÕÐÆ¸²©Ê¿ºó
+1/12
Öйú¿ÆÑ§ÔºÇຣÑκþÑо¿Ëù£¨½çÃæÎïÀí»¯Ñ§¡¢Á÷ÌåÁ¦Ñ§·½Ïò )¿ÆÑиÚÕÐÆ¸
+1/9
»¶Óµ÷¼Áµ½Ö£ÖÝÇṤҵ´óѧ²ÄÁÏÓ뻯ѧ¹¤³ÌѧԺ
+1/8
Î÷°²¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤×¨ÒµÏȽøµç×Ó²ÄÁÏÓëÆ÷¼þ¿ÎÌâ×éרҵ²©Ê¿ÕÐÉú
+1/8
ºþÄÏÀí¹¤´óѧ »¯Ñ§¡¢»¯¹¤µ÷¼ÁÖ¸±ê³ä×㣬¼ȡÂʸߣ¬µ÷¼Áϵͳ×îºóÒ»´Î¿ª·Å
+1/8
»ªÄÏʦ·¶´óѧ»·¾³Ñ§Ôº´ó·Ö×ÓÌåϵ¶à³ß¶ÈÄ£ÄâÓëʵÑéÑо¿ÍŶÓÕÐÊÕ2026Ä꿼Ñе÷¼ÁÉú1Ãû
+1/5
2026ÄêÖйúÀͶ¯¹ØÏµÑ§Ôº»·¾³Óë×ÊÔ´£¨°²È«¹¤³ÌÁìÓò£©×¨ÒµË¶Ê¿Ñо¿Éúµ÷¼Á¸´ÊÔ£¨µÚÈýÂÖ£©
+1/3
´óÁ¬º£Ñó´óѧ×ÊÔ´Óë»·¾³×¨Ë¶£¨0857£©½ÓÊÕµ÷¼ÁѧÉú
+1/1
µØÍ¼ÎÏÅ£
Òø³æ (СÓÐÃûÆø)
- ·ÒëEPI: 9
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 339.4
- Ìû×Ó: 71
- ÔÚÏß: 16.5Сʱ
- ³æºÅ: 804596
ЦÊÀ¿ñÁú(½ð±Ò+25, ·ÒëEPI+1): ллÄã 2011-03-11 20:27:42
|
ÄúÊDz»ÊǰÑһƪDPDµÄ×ÛÊöÒ»µãµãÌùѽ¡£ ĿǰÒѱ¨µÀÓжà¸öÍ»±äµ¼ÖÂÍêÈ«¹¦ÄÜȱʧ£¬ÕâЩͻ±äÓУºÁ½¸öȱʧͻ±ä£¨295¨C298delTCAT and 1897delC£©£¬Ò»¸ö¼ô½ÓλµãÍ»±ä(IVS14+IG>A)£¬4¸ö´íÒåÍ»±ä(85T>C, 703C>T, 2657G>A, and 2983 G>T)£¬Ò»¸öÁ½¸öºËÜÕËáµÄȱʧͻ±ä(1039¨C1040delTG)ºÍ¼¸¸öµãÍ»±äP86L, S201R, S492L, D949V and H978R¡£85T>CÍ»±ä¿ÉÄÜÊÇÒ»¸ö±È½ÏÆÕ±éµÄ¶à̬ÐÔ£¬µ«Ð¯´ø85T>CÍ»±äµÄÖØ×éÈËDPDµ°°×²¢Ã»ÓÐÃ÷ÏÔµÄÍ»±äøµÄ»îÐÔ²ÐÓà¡£´óÁ¿×ÛÊöÒѾÉîÈëÌÖÂÛÁËDPDµÄÖØÒªÁÙ´²×÷Óã¬ÎÄÏ×37£¬38ÖоÍÓÐÁ½¸öÀý×Ó£¬ÕâÁ½Æª×ÛÊöÌÖÂÛÁËDPDÔÚ5FUÖÎÁư©Ö¢ÖеÄ×÷Óᣠ|
2Â¥2011-03-11 10:50:33
3Â¥2011-03-11 20:40:20













»Ø¸´´ËÂ¥